Venus Remedies Limited

NSE VENUSREM.NS

Venus Remedies Limited Dividend Yield on February 06, 2025: 0.00%

Venus Remedies Limited Dividend Yield is 0.00% on February 06, 2025, a 0.00% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.
  • Venus Remedies Limited 52-week high Dividend Yield is 0.00% on February 06, 2025, which is 0.00% below the current Dividend Yield.
  • Venus Remedies Limited 52-week low Dividend Yield is 0.00% on February 06, 2025, which is 0.00% below the current Dividend Yield.
  • Venus Remedies Limited average Dividend Yield for the last 52 weeks is 0.00%.
Key data
Date Dividend Yield Free Cash Flow Yield Earnings Yield Enterprise Value (EV)
Market news
Loading...
SV Wall Street
NSE: VENUSREM.NS

Venus Remedies Limited

CEO Mr. Ashutosh Jain B.A., LL.B
IPO Date Dec. 20, 2006
Location India
Headquarters Plot 51-52, Industrial Area
Employees 1,187
Sector Healthcare
Industries
Description

Venus Remedies Limited develops and markets pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, anticoagulant, cardiac, disinfectant and antiseptic, gastro therapy, hand sanitizers, hormones, iron supplements, neurology, oncology, pain management, respiratory, skin and wound care, stress reliever, urology, and vitamins/minerals/nutrients, as well as antimicrobial resistance products. It also provides disinfectants; and a portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India.

Similar companies

THEMISMED.NS

Themis Medicare Limited

USD 2.71

-0.36%

INDOCO.NS

Indoco Remedies Limited

USD 3.19

1.00%

SMSPHARMA.NS

SMS Pharmaceuticals Limited

USD 2.47

1.65%

RPGLIFE.NS

RPG Life Sciences Limited

USD 28.88

1.88%

VIMTALABS.NS

Vimta Labs Limited

USD 11.90

11.12%

StockViz Staff

February 8, 2025

Any question? Send us an email